Lecanemab (Leqembi; Eisai/Biogen) received traditional approval from the FDA in July 2023, following an accelerated approval ...

During CHEST 2024, Maxine Dexter, MD, Kaiser Permanente, discussed her belief in the vital role of physicians in public health advocacy, drawing from her legislative work on issues as a former Oregon ...

The American Journal of Managed Care provides insights into the latest news and research in managed care across multimedia ...

The American Journal of Managed Care provides insights into the latest news and research in managed care across multimedia ...

The American Journal of Managed Care provides insights into the latest news and research in managed care across multimedia ...

The American Journal of Managed Care provides insights into the latest news and research in managed care across multimedia ...

The American Journal of Managed Care provides insights into the latest news and research in managed care across multimedia platforms.

Ticiana Leal, MD, Winship Cancer Institutes, explains the importance of biomarker testing and multidisciplinary conversations while caring for patients with early-stage non–small cell lung cancer ...

Vold, MD, PhD, a senior consultant and leader of inflammatory and fibrotic research area at Oslo University Hospital, discusses therapies and management guidelines for patients with interstitial lung ...

Imuldosa (ustekinumab-srlf) is the fifth ustekinumab biosimilar referencing Stelara to receive regulatory approval in the US.

Outcomes of interest in this study were time from diagnosis to initial prescription fill for an oral multiple myeloma (MM) ...

The American Journal of Managed Care provides insights into the latest news and research in managed care across multimedia ...